Blog

Sep 16, 2020
The Medicines and Medical Devices Bill is continuing to progress through the House of Lords. After its second reading in the House of Lords on the 2nd September, the legislation is now passing through a Committee stage. Further amendments to the Bill have now been published from this stage as a prelude to their review by a House of Lords Grand Committee. The Committee stage in the House of Lords involves detailed line by line examination of the separate parts (clauses and schedules) of a Bill. S...
Read More
Sep 11, 2020
Two new consultations have been released by Government to which BIVDA is considering an association response on behalf of members. Members are welcome to put forward contributions or comments to these papers, please send there to helen@bivda.org.uk. The first is based on the UK National Data Strategy and the second on Artificial Intelligence and Intellectual Property. A summary of these is attached below.
Read More
Sep 09, 2020
 A report on diabetes care titled ‘A Vision for Digitally Enabled Diabetes Care in Europe’ has been published by MedTech Europe. The authors of the text are John J. Nolan, Adjunct Professor, Department of Clinical Medicine, Trinity College Dublin and Tanja Valentin, Director of External Affairs, MedTech Europe. The text includes views from critical stakeholders within the diabetes and wider healthcare community. Around 60 million people with diabetes live in the European Region ...
Read More
Sep 04, 2020
Drug Tariff CommitteeThere has been a collaboration between a number of Trade Associations including BIVDA since 2005 to support products prescribed in primary care and reimbursed through the Drug Tariff (Part IX). This covers a huge number of items from stoma care and wound care as well as testing strips for product like blood glucose meters. Potentially any diagnostic used in the community could be prescribed and it may be a route which has been under-utilised. The Drug Tariff Committee has pr...
Read More
Sep 02, 2020
The Scottish Government has published new guidance for the life sciences sector relating to coronavirus. It sets out the work of the sector in terms of test supply chain, vaccine development and the repurposing of drugs. The report is a part of the Scottish Government’s ‘Test and Protect’ priorities outlined in documents published in April and August 2020. Strategic ambitions are to expand the sector’s turnover to £8 billion in 2025. NHS National Services Scotland, ...
Read More
Aug 24, 2020
Scientists have begun work on methods to study virus RNA at a single-cell level in order to better understand COVID-19 reproduction and other viral processes. The pandemic has given rise to many important questions around virus spreading, reproduction and immunological responses. Also, key answers will be needed on the ability of viruses to evade treatment or vaccine approaches. In one of the attempts to find answers to these conundrums, scientists at Rutgers University have a new project dedica...
Read More
Aug 19, 2020
The new video discusses IVD innovation and the urgent NHS procedural backlog.
Read More
Aug 14, 2020
Please complete and send the attached form to the email address in the document by 11th September. 
Read More
Jul 30, 2020
As part of the NHS England and NHS Improvement board meeting held yesterday, the ‘Phase 3’ stage of the COVID-19 response and NHS recovery was set out. The proposed approach to planning for the ongoing recovery of NHS services in the remainder of 2020/21 and progress on the restoration of urgent and critical services and the constraining factors were outlined. In relation to the diagnostic sector, the notes state that, “we will maximise diagnostic capacity, inclu...
Read More
Jul 24, 2020
Please see below an attachment with the latest slides from the 23rd July Government Webinar update on REACT studies and COVID-19 Commercial Impacts.BIVDA's Chief Operating Officer Helen Dent was also one of the speakers on the online event. 
Read More
Page 3 of 11 [3]